32 Epidemiology of heart failure in south asia

Q2 Medicine Heart Asia Pub Date : 2019-04-01 DOI:10.1136/heartasia-2019-apahff.32
A. Roy
{"title":"32 Epidemiology of heart failure in south asia","authors":"A. Roy","doi":"10.1136/heartasia-2019-apahff.32","DOIUrl":null,"url":null,"abstract":"South Asia has seen rapid epidemiological transition in the last two decades with a rapid rise in cardiovascular diseases, which have emerged as the leading cause of mortality in this region. In India the leading cause of disability adjusted life years is ischaemic heart disease which has seen a 104% increase between 1990 and 2016.1 Similarly the burden of obesity, hypertension and diabetes mellitus has increased markedly over this time and with poor control rates for these risk factors leading to a fertile soil for rise in incidence of heart failure.2 In the absence of active surveillance mechanisms reliable estimates of heart failure burden is missing. However, one study estimates it to the tune of 4.6 million which is probably a severe under-estimate given the risk factor burden.3 The study of the heart failure patients in two large registries, INTER-CHF and Trivandrum Heart Failure Registry,4 5 revealed disturbingly high mortality rates of 23% and 31%, respectively. This was much higher than that of patients from other low and middle income countries.4 The chief driver of this mortality seems to be suboptimal medical management of these patients with a large percentage not receiving beta-blockers and renin-angiotensin aldosterone inhibitors; drugs known to improve survival. Thus, quality improvement program using guideline-directed medical therapy will go a long way in improving survival of these patients. References India State-Level Disease Burden Initiative Collaborators. (2017). Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. Lancet 2017;390: 2437–2460. Prabhakaran D, Roy A, Praveen PA, Ramakrishnan L, Gupta R, Amarchand R, Kondal D, Singh K, Sharma M, Shukla DK, Tandon N, Reddy KS, Krishnan A. 20-year trend of CVD risk factors: urban and rural national capital region of India. Glob Heart 2017;12:209–217. Huffman MD, Prabhakaran D. Heart failure: epidemiology and prevention in India. Natl Med J India 2010;23:283–288. Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, Palileo-Villaneuva L,Lopez-Jaramillo P, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Prabhakaran D, Badr A, Elmaghawry M, Damasceno A, Tibazarwa K, Belley-Cote E, Balasubramanian K, Islam S, Yacoub MH, Huffman MD, Harkness K, Grinvalds A, McKelvie R, Bangdiwala SI, Yusuf S; INTER-CHF Investigators. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health 2017;5:e665–e672. Harikrishnan S, Sanjay G, Agarwal A, Kumar NP, Kumar KK, Bahuleyan CG, Vijayaraghavan G, Viswanathan S, Sreedharan M, Biju R, Rajalekshmi N, Nair T, Suresh K, Jeemon P. One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India. Am Heart J 2017;189:193–199.","PeriodicalId":12858,"journal":{"name":"Heart Asia","volume":"11 1","pages":"A13 - A14"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/heartasia-2019-apahff.32","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/heartasia-2019-apahff.32","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

South Asia has seen rapid epidemiological transition in the last two decades with a rapid rise in cardiovascular diseases, which have emerged as the leading cause of mortality in this region. In India the leading cause of disability adjusted life years is ischaemic heart disease which has seen a 104% increase between 1990 and 2016.1 Similarly the burden of obesity, hypertension and diabetes mellitus has increased markedly over this time and with poor control rates for these risk factors leading to a fertile soil for rise in incidence of heart failure.2 In the absence of active surveillance mechanisms reliable estimates of heart failure burden is missing. However, one study estimates it to the tune of 4.6 million which is probably a severe under-estimate given the risk factor burden.3 The study of the heart failure patients in two large registries, INTER-CHF and Trivandrum Heart Failure Registry,4 5 revealed disturbingly high mortality rates of 23% and 31%, respectively. This was much higher than that of patients from other low and middle income countries.4 The chief driver of this mortality seems to be suboptimal medical management of these patients with a large percentage not receiving beta-blockers and renin-angiotensin aldosterone inhibitors; drugs known to improve survival. Thus, quality improvement program using guideline-directed medical therapy will go a long way in improving survival of these patients. References India State-Level Disease Burden Initiative Collaborators. (2017). Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. Lancet 2017;390: 2437–2460. Prabhakaran D, Roy A, Praveen PA, Ramakrishnan L, Gupta R, Amarchand R, Kondal D, Singh K, Sharma M, Shukla DK, Tandon N, Reddy KS, Krishnan A. 20-year trend of CVD risk factors: urban and rural national capital region of India. Glob Heart 2017;12:209–217. Huffman MD, Prabhakaran D. Heart failure: epidemiology and prevention in India. Natl Med J India 2010;23:283–288. Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, Palileo-Villaneuva L,Lopez-Jaramillo P, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Prabhakaran D, Badr A, Elmaghawry M, Damasceno A, Tibazarwa K, Belley-Cote E, Balasubramanian K, Islam S, Yacoub MH, Huffman MD, Harkness K, Grinvalds A, McKelvie R, Bangdiwala SI, Yusuf S; INTER-CHF Investigators. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health 2017;5:e665–e672. Harikrishnan S, Sanjay G, Agarwal A, Kumar NP, Kumar KK, Bahuleyan CG, Vijayaraghavan G, Viswanathan S, Sreedharan M, Biju R, Rajalekshmi N, Nair T, Suresh K, Jeemon P. One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India. Am Heart J 2017;189:193–199.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
32 南亚心力衰竭的流行病学
在过去二十年中,南亚的流行病学发生了快速转变,心血管疾病迅速上升,成为该地区死亡的主要原因。在印度,残疾调整寿命的主要原因是缺血性心脏病,该疾病在1990年至2016年间增加了104%。1同样,肥胖的负担,高血压和糖尿病在这段时间内显著增加,这些风险因素的控制率低,导致心力衰竭发病率上升。2在缺乏积极监测机制的情况下,缺乏对心力衰竭负担的可靠估计。然而,一项研究估计为4.6 万,考虑到风险因素负担,这可能是一个严重低估的数字。3对两个大型登记处(INTER-CHF和Trivandrum心力衰竭登记处)的心力衰竭患者的研究显示,令人不安的高死亡率分别为23%和31%。这远高于其他中低收入国家的患者。4这种死亡率的主要驱动因素似乎是这些患者的医疗管理不理想,其中很大一部分患者没有接受β受体阻滞剂和肾素-血管紧张素-醛固酮抑制剂;已知能提高生存率的药物。因此,采用指南指导的药物治疗的质量改进计划将大大提高这些患者的生存率。参考文献印度国家级疾病负担倡议合作者。(2017)。国家内部的国家:1990年至2016年全球疾病负担研究中印度各州流行病学转变的变化。《柳叶刀》2017;390:2437-2460。Prabhakaran D、Roy A、Praveen PA、Ramakrishnan L、Gupta R、Amarchand R、Kondal D、Singh K、Sharma M、Shukla DK、Tandon N、Reddy KS、Krishnan A.心血管疾病风险因素的20年趋势:印度国家首都城市和农村地区。环球之心2017;12:209–217.Huffman医学博士,Prabhakaran D.心力衰竭:印度的流行病学和预防。印度国家医学杂志2010;23:283–288.Dokainish H、Teo K、Zhu J、Roy A、AlHabib KF、ElSayed A、Palileo Villaneuva L、Lopez Jaramillo P、Karaye K、Yusoff K、Orlandini A、Sliwa K、Mondo C、Lanas F、Prabhakaran D、Badr A、Elmaghawry M、Damasceno A、Tibazarwa K、Belley Cote E、Balasubramanian K、Islam S、Yacoub MH、Huffman MD、Harkness K、Grinvalds A、McKelvie R、Bangdiwala SI、Yusuf S;INTER-CHF调查人员。心力衰竭患者的全球死亡率变化:国际充血性心力衰竭(INTER-CHF)前瞻性队列研究的结果。柳叶刀全球健康2017;5:e665–e672。Harikrishnan S、Sanjay G、Agarwal A、Kumar NP、Kumar KK、Bahulyan CG、Vijayaraghavan G、Viswanathan S、Sreedharan M、Biju R、Rajalekshmi N、Nair T、Suresh K、Jeemon P。急性心力衰竭患者的一年死亡率结果和再次入院:来自印度喀拉拉邦Trivandrum心力衰竭登记处的数据。Am Heart J 2017;189:193-199。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Heart Asia
Heart Asia Medicine-Cardiology and Cardiovascular Medicine
CiteScore
2.90
自引率
0.00%
发文量
0
期刊最新文献
Antiplatelet agents for preventing pre-eclampsia and its complications. Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan. Anaesthesia use in catheter ablation for atrial fibrillation: a systematic review and meta-analysis of observational studies Association of school hours with outcomes of out-of-hospital cardiac arrest in schoolchildren Clinical consequences of poor adherence to lipid-lowering therapy in patients with cardiovascular disease: can we do better?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1